This document discloses the conflicts of interest and funding sources for Dr. Atul Butte, the director of the Institute for Computational Health Sciences at UCSF. It lists that Dr. Butte has financial interests in several biotech companies, serves as a consultant or advisor for numerous pharmaceutical companies, and receives honoraria for speaking engagements. It also outlines the corporate relationships, speakers' bureaus, and companies started by his students that he is involved with. Finally, it provides details on funding support received from various organizations including government agencies, foundations, and industry groups.
Atul Butte's presentation to the Association of Medical School Pediatric Department Chairs #AMSPDC on March 3, 2018.
Some pre-publication data slides have been removed from this deck.
The Uneven Future of Evidence-Based MedicineIda Sim
An Apple ResearchKit study enrolled 22,000 people in five days. A
study claims that Twitter can be used to identify depressed patients. A computer program crunches genomic data, the published literature, and electronic health record data to guide cancer treatment. The pace, the data sources, and the methods for generating medical evidence are changing radically. What will — what should — evidence-based medicine look like in a faster, personalized, data-dense tomorrow?
- Presented as the 3rd Annual Cochrane Lecture, October 2015 in Vienna, Austria.
This edition of Pencil Shavings captures the fourth Global Product Committee meeting of 2014, held last month in Beijing. In addition to the 4Q14 collection of 8-ball and 7+ work, this issue includes a profile of LB Sri Lanka (Colombo), coverage of the 2014 Agency of the Year Awards and much more.
Atul Butte's presentation to the Association of Medical School Pediatric Department Chairs #AMSPDC on March 3, 2018.
Some pre-publication data slides have been removed from this deck.
The Uneven Future of Evidence-Based MedicineIda Sim
An Apple ResearchKit study enrolled 22,000 people in five days. A
study claims that Twitter can be used to identify depressed patients. A computer program crunches genomic data, the published literature, and electronic health record data to guide cancer treatment. The pace, the data sources, and the methods for generating medical evidence are changing radically. What will — what should — evidence-based medicine look like in a faster, personalized, data-dense tomorrow?
- Presented as the 3rd Annual Cochrane Lecture, October 2015 in Vienna, Austria.
This edition of Pencil Shavings captures the fourth Global Product Committee meeting of 2014, held last month in Beijing. In addition to the 4Q14 collection of 8-ball and 7+ work, this issue includes a profile of LB Sri Lanka (Colombo), coverage of the 2014 Agency of the Year Awards and much more.
Liztek HDDT2BS Dual Bay USB 3.0 Super Speed 2.5 and 3.5 inch SATA Hard Disk Drive and Solid-State Drive External Docking Station Duplicator/Cloner TB Support.
http://goo.gl/mDTaHx
The holiday season is fast approaching. This slideshare includes best practices, tips, tricks, and an email marketing calendar to help you succeed this holiday season, as well as key customer segments and email design tips.
Toronto Society of Architects 2013 Yearbooktosoarch
Each year the Toronto Society of Architects holds its annual fundraiser at a great new space in the city. December 2 2013 was no different as we celebrated in the St. James Cathedral Centre by architects Alliance, ERA Architects (Heritage Consultant), NAK Design Group (Landscape Architects) and Lynch+Comisso Architects (Lighting Design). The TSA invites its members and Sponsors to submit their favourite projects from 2013, built, unbuilt or future built, and we present them in a looping slide show at our year end Bash.
En nuestra lista puede encontrar información de precios, promociones de todos nuestros productos, actualizada según la fechas del documento. Vigencia hasta el 30 de Agosto de 2012
http://www.compugreiff.com
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...Hyper Wellbeing
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Professor, Institute of Systems Biology)
Delivered at the inaugural Hyper Wellbeing Summit, 14th November 2016, Mountain View, California.
For more information including details of subsequent events, please visit http://hyperwellbeing.com
The summit was created to foster a community around an emerging industry - Wellness as a Service (WaaS). Consumer technologies, in particular wearables and mobile, are powering a consumer revolution. A revolution to turn health and wellness into platform delivered services. A revolution enabling consumer data-driven disease risk reduction. A revolution extending health care past sick care towards consumer-led lifelong health, wellness and lifestyle optimization.
WaaS newsletter sign-up http://eepurl.com/b71fdr
@hyperwellbeing
PREDICT Study ASN Presentation June 2020Sara Gordon
Sarah Berry, Nicola Segata, Jose Ordovas and Tim Spector reveal novel findings from the world's largest ongoing nutrition study, PREDICT. The presentation shares learnings on how we metabolize food, the importance of food sequencing and combining, the gut microbiome and inflammation. These findings are some of the most cutting edge in the field of nutrition science, highlighting the need for precision nutrition. Learn more at www.joinzoe.com/science
Remote presentation by Atul Butte at the NSTC Interagency Working Group on Biological Data Sharing on 2019-06-12.
The working group is charged by the National Science and Technology Council to develop a road map to enable robust sharing and maximize reuse of biological data, identifying opportunities for interagency coordination, and academic, industrial, and international partnerships. The workshop will bring together a diverse community of government, academic, and industrial stakeholders to identify key bottlenecks and challenges that interfere with the open exchange of information and to identify potential solutions that will accelerate biological science research.
Tratamiento antirretroviral combinado en dosis fija en un comprimido (STR) con Inhibidores de la proteasa (IP) y tenofovir alafenamida (TAF) para pacientes con diagnóstico de VIH. Pacientes VIH NAIVE, inicio de tratamiento precoz y simplificación (Swich). Postgrado. Dirigido a las siguientes especialidades: Clínica médica, infectología, atención primaria con experencia en la asistencia de pacientes con diagnóstico de VIH.
Systematic Review on Eat Less and Move More Is the Chemistry of Lifeijtsrd
"Dieting must be combined with exercise" This review explain the physical activity and exercise training are play vital role for weight loss or weight maintenance. To see prevention is better than cure, the patient is carried out 60 different tests by giving one time blood sample after fasting 12 14 hours. Eat less is the probable basic advice to lose weight. Increasing your vegetable intake can help you to lose weight. In this particular discussion, we focus on weight loss from different types of exercise training programs and calorie consumes. Clinically required weight loss is unlikely to occur. Patients wishing to lose weight should participate in physical activity and caloric restriction to improve the chances of weight loss. The less you consume, the faster you lose. At the same time, it is very important to follow a healthy, well balanced diet plan, so that you do not become ill or lose lean muscle. In ideal condition the advice of doctor, dietitian and nutritionist is must essential. The tests such as eosinohils, MCV, MCHC, RDW SD, Total cholesterol, LDL cholesterol, Non HDL cholesterol, TC HDL cholesterol ratio, LDL HDL ratio etc shows some deviations from the reference ranges as per the guidelines. S. M. Landge | M. G. Landge "Systematic Review on Eat Less and Move More; Is the Chemistry of Life?" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30909.pdf Paper Url :https://www.ijtsrd.com/engineering/mechanical-engineering/30909/systematic-review-on-eat-less-and-move-more-is-the-chemistry-of-life/s-m-landge
2020-03-08 Atul Butte's keynote for the AMIA Virtual Informatics Summit
Atul Butte's AAPS big data workshop presentation 6/2015
1. Open Big Data in Biomedicine
Atul Butte, MD, PhD
Director, Institute for
Computational Health Science
University of California, San Francisco
atul.butte@ucsf.edu
@atulbutte
@ImmPortDB
2. Disclosures
• Scientific founder and
advisory board membership
– Genstruct
– NuMedii
– Personalis
– Carmenta
• Honoraria for talks
– Lilly
– Pfizer
– Siemens
– Bristol Myers Squibb
– AstraZeneca
– Roche
– Genentech
– Warburg Pincus
• Past or present consultancy
– Lilly
– Johnson and Johnson
– Roche
– NuMedii
– Genstruct
– Tercica
– Ecoeos
– Ansh Labs
– Prevendia
– Samsung
– Assay Depot
– Regeneron
– Verinata
– Pathway Diagnostics
– Geisinger Health
– Covance
– Wilson Sonsini Goodrich & Rosati
– 10X Genomics
– Medgenics
– GNS Healthcare
– Gerson Lehman Group
– Coatue Management
• Corporate Relationships
– Northrop Grumman
– Aptalis
– Thomson Reuters
– Intel
– SAP
– SV Angel
• Speakers’ bureau
– None
• Companies started by students
– Carmenta
– Serendipity
– NuMedii
– Stimulomics
– NunaHealth
– Praedicat
– MyTime
– Flipora
6. Already nearly 1.7 million microarrays publicly-available
Doubles every 2-3 years
Butte AJ. Translational Bioinformatics: coming of age. JAMIA, 2008.
12. 170 million substances x
1.1 million assays
More than a billion
measurements within a
grid of 190 trillion cells
122 million meet Lipinski 5
1 million active substances
13. • One example of a
microarray experiment
with diabetes and
control samples
• 187 genes differentially
expressed
Any one experiment does not yield
clear disease-causal factors
14.
15. Keiichi Kodama
Relativefrequency
# of positive RNA microarray experiments (out of 130)
Intersect 130 T2D microarray experiments
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
16. Keiichi Kodama
Relativefrequency
# of positive RNA microarray experiments (out of 130)
Intersect 130 T2D microarray experiments
Most of the 25000 genes in the
genome are positive in few T2D
microarray experiments
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
17. Keiichi Kodama
Relativefrequency
# of positive RNA microarray experiments (out of 130)
Intersect 130 T2D microarray experiments
TCF7L2
PPARG
IDE
LEPR
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
The 186 best known drug targets or
genes with DNA variants (from
GWAS) are positive in more
experiments
18. Keiichi Kodama
Close collaboration with Dr. Takashi Kadowaki, Momoko Horikoshi,
Kazuo Hara, University of Tokyo
Relativefrequency
# of positive RNA microarray experiments (out of 130)
Intersect 130 T2D microarray experiments
A
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
19. Keiichi Kodama
Gene A changes the most in adipose tissue
and islet cell experiments
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
20. Keiichi Kodama
Kyoko Toda
Gene A is higher in high fat diet
Gene A is expressed in mouse fat infiltrate
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
21. Gene A knockout has reduced infiltrate in fat
Keiichi Kodama
Kyoko Toda
• Mac-2 stain
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
22. Gene A knockout has increased insulin sensitivity
Keiichi Kodama
Kyoko Toda
• No change in weight gain
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
23. Keiichi Kodama
Inflammatory infiltrate in human fat
Protein of Gene A
• Paraffin-embedded omental adipose tissue from an
obese 57 year woman, BMI 36.9 kg/m2
• Analyzed for Protein A immunoreactivity
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
24. Keiichi Kodama
Momoko Horikoshi
Serum soluble Gene A protein
correlates with human HbA1c and insulin resistance
• n = 55 non-diabetics
• 60.3 years of age ± 15, 36 males, 19 females
• BMI 23.2 ± 4.3 kg/m2
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
26. Keiichi Kodama
Therapeutic antibody against Gene A reduces glucose
• C57BL6/6J fed high-fat diet for 18 weeks
• Intraperitoneal injection of rat anti-mouse anti-A antibody (n=8) or isotype
control (n=8)
• 100 μg at day 0 and 50 μg at day 1-7
Kodama K, Horikoshi M, ..., Maeda S, Kadowaki T, Butte AJ. PNAS, 2012.
27. Keiichi Kodama
• Gene A is CD44 (Hyaluronic Acid Receptor)
• Anti-CD44 in development for multiple cancers
• CD44 is a complicated receptor
Ponta, Sherman, Herrlich. Nature Reviews Molecular Cell Biology, 2003.
28. Longer-term trial of anti-CD44 as a prototype therapy for
type 2 diabetes
Kodama K, …, Butte AJ. Diabetes, 2015 Mar;64(3):867-75.
Keiichi Kodama
Kyoko Toda
Shojiroh Morinaga
Satoru Yamada
29. Anti-CD44 for 4 weeks reduces fasting glucose and
improves insulin sensitivity
Kodama K, …, Butte AJ. Diabetes, 2015 Mar;64(3):867-75.
Keiichi Kodama
Kyoko Toda
Shojiroh Morinaga
Satoru Yamada
30. Kodama K, …, Butte AJ. Diabetes, 2015 Mar;64(3):867-75.
Keiichi Kodama
Kyoko Toda
Shojiroh Morinaga
Satoru Yamada
Anti-CD44 for 4 weeks slows weight gain and reduces intake
31. Anti-CD44 for 4 weeks reduces adipose inflammation and
hepatic steatosis
Kodama K, …, Butte AJ. Diabetes, 2015 Mar;64(3):867-75.
Keiichi Kodama
Kyoko Toda
Shojiroh Morinaga
Satoru Yamada
32. Kodama K, …, Butte AJ. Diabetes, 2015.
Keiichi Kodama
Kyoko Toda
Shojiroh Morinaga
Satoru Yamada
37. Collaborators
• Jeff Wiser, Patrick Dunn, Mike Atassi / Northrop Grumman
• Ashley Xia and Quan Chen / NIAID
• Takashi Kadowaki, Momoko Horikoshi, Kazuo Hara, Hiroshi Ohtsu / U Tokyo
• Kyoko Toda, Satoru Yamada, Junichiro Irie / Kitasato Univ and Hospital
• Shiro Maeda / RIKEN
• Alejandro Sweet-Cordero, Julien Sage / Pediatric Oncology
• Mark Davis, C. Garrison Fathman / Immunology
• Russ Altman, Steve Quake / Bioengineering
• Euan Ashley, Joseph Wu, Tom Quertermous / Cardiology
• Mike Snyder, Carlos Bustamante, Anne Brunet / Genetics
• Jay Pasricha / Gastroenterology
• Rob Tibshirani, Brad Efron / Statistics
• Hannah Valantine, Kiran Khush/ Cardiology
• Ken Weinberg / Pediatric Stem Cell Therapeutics
• Mark Musen, Nigam Shah / National Center for Biomedical Ontology
• Minnie Sarwal / Nephrology
• David Miklos / Oncology
38. Support
• Lucile Packard Foundation for Children's Health
• NIH: NIAID, NLM, NIGMS, NCI; NIDDK, NHGRI, NIA, NHLBI, NCATS
• March of Dimes
• Hewlett Packard
• Howard Hughes Medical Institute
• California Institute for Regenerative Medicine
• Luke Evnin and Deann Wright (Scleroderma Research Foundation)
• Clayville Research Fund
• PhRMA Foundation
• Stanford Cancer Center, Bio-X, SPARK
• Tarangini Deshpande
• Sam Hawgood
• Keith Yamamoto
• Isaac Kohane
Admin and Tech Staff
• Mary Lyall
• Mounira Kenaani
• Kevin Kaier
• Boris Oskotsky